MENU

ATYR aTyr Pharma Inc Forecast, Technical & Fundamental Analysis

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions... Show more

ATYR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ATYR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ATYR is expected to report earnings to fall 7.82% to -10 cents per share on November 05

aTyr Pharma Inc ATYR Stock Earnings Reports
Q3'26
Est.
$-0.10
Q1'26
Beat
by $0.03
Q4'25
Beat
by $0.04
Q3'25
Missed
by $0.09
Q2'25
Missed
by $0.04
The last earnings report on May 15 showed earnings per share of -10 cents, beating the estimate of -13 cents. With 302.01K shares outstanding, the current market capitalization sits at 49.19M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GOIOX39.200.47
+1.21%
JHancock International Growth 1
UIVPX13.870.16
+1.17%
MFS Intrinsic Equity R3
AFCNX18.940.20
+1.07%
American Century Focused Intl Gr Inv
FILRX18.160.18
+1.00%
Franklin Intl Growth R6
SPFAX31.240.17
+0.55%
PGIM Jennison Focused Growth A

ATYR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with AMLX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
-0.30%
AMLX - ATYR
39%
Loosely correlated
-2.52%
IDYA - ATYR
39%
Loosely correlated
+1.43%
SLDB - ATYR
39%
Loosely correlated
+2.20%
NTLA - ATYR
38%
Loosely correlated
+3.22%
CRNX - ATYR
37%
Loosely correlated
N/A
More
aTyr Pharma (ATYR) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com